Revolution Medicines (RVMD)
Revolution Medicines on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
12.9M
Short interest
settlement 2026-10-15
6.1
Days to cover
+1.5 days vs prior
54.6%
Short share of volume
2026-10-28
119
Fails to deliver
settlement 2026-09-24
Wed 4 Nov
Next earnings
estimated date
-$78.4M
Insider flow, 90 days
0 buys, 80 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in RVMD is 12,934,780 shares, up 3,265,623 shares over the last month. Over the last 48 readings it ranged from 9,669,157 shares (15 September 2026) to 19,363,548 shares (15 October 2025). At the reported average volume of 2.1M shares a day that is 6.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rvmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 12,934,780 | +8.5% | 2,110,717 | 6.13 |
| 2026-09-30 | 11,925,485 | +23.3% | 2,564,736 | 4.65 |
| 2026-09-15 | 9,669,157 | -0.6% | 1,334,613 | 7.24 |
| 2026-08-31 | 9,727,133 | +0.1% | 2,075,241 | 4.69 |
| 2026-08-14 | 9,716,949 | -15.7% | 1,528,603 | 6.36 |
| 2026-07-31 | 11,519,784 | -17.7% | 1,834,387 | 6.28 |
| 2026-07-15 | 14,002,778 | +8.7% | 2,060,932 | 6.79 |
| 2026-06-30 | 12,882,513 | +4.9% | 4,308,352 | 2.99 |
| 2026-06-15 | 12,282,512 | +6.0% | 2,850,843 | 4.31 |
| 2026-05-29 | 11,588,154 | +4.6% | 2,750,932 | 4.21 |
| 2026-05-15 | 11,075,199 | -13.5% | 2,349,181 | 4.71 |
| 2026-04-30 | 12,799,582 | -4.4% | 3,907,552 | 3.28 |
| 2026-04-15 | 13,387,469 | -13.1% | 4,402,996 | 3.04 |
| 2026-03-31 | 15,409,530 | +6.6% | 1,943,343 | 7.93 |
| 2026-03-13 | 14,457,743 | +2.4% | 1,860,881 | 7.77 |
| 2026-02-27 | 14,113,308 | +3.4% | 2,629,824 | 5.37 |
| 2026-02-13 | 13,655,708 | +4.5% | 1,980,171 | 6.90 |
| 2026-01-30 | 13,072,474 | -8.0% | 3,980,203 | 3.28 |
| 2026-01-15 | 14,216,021 | -7.2% | 7,051,184 | 2.02 |
| 2025-12-31 | 15,314,358 | +1.6% | 2,347,443 | 6.52 |
| 2025-12-15 | 15,070,669 | -10.3% | 2,215,904 | 6.80 |
| 2025-11-28 | 16,792,419 | -4.0% | 2,051,630 | 8.18 |
| 2025-11-14 | 17,485,484 | -3.0% | 2,723,493 | 6.42 |
| 2025-10-31 | 18,022,242 | -6.9% | 2,269,044 | 7.94 |
| 2025-10-15 | 19,363,548 | +7.8% | 1,967,812 | 9.84 |
| 2025-09-30 | 17,968,076 | -0.5% | 2,185,977 | 8.22 |
| 2025-09-15 | 18,053,357 | +9.2% | 2,252,642 | 8.01 |
| 2025-08-29 | 16,527,230 | +8.9% | 1,831,660 | 9.02 |
| 2025-08-15 | 15,175,192 | +8.9% | 2,126,122 | 7.14 |
| 2025-07-31 | 13,930,629 | +2.0% | 1,502,625 | 9.27 |
| 2025-07-15 | 13,662,930 | -15.1% | 1,784,598 | 7.66 |
| 2025-06-30 | 16,101,450 | -11.3% | 4,746,649 | 3.39 |
| 2025-06-13 | 18,157,402 | -1.1% | 1,429,305 | 12.70 |
| 2025-05-30 | 18,356,999 | -2.8% | 1,843,351 | 9.96 |
| 2025-05-15 | 18,880,783 | +14.1% | 2,133,877 | 8.85 |
| 2025-04-30 | 16,548,393 | +0.7% | 1,816,990 | 9.11 |
| 2025-04-15 | 16,427,758 | +1.4% | 2,468,322 | 6.66 |
| 2025-03-31 | 16,197,707 | -2.7% | 1,176,016 | 13.77 |
| 2025-03-14 | 16,652,995 | +5.1% | 1,428,391 | 11.66 |
| 2025-02-28 | 15,839,448 | +6.1% | 1,326,206 | 11.94 |
| 2025-02-14 | 14,924,861 | -6.2% | 1,166,240 | 12.80 |
| 2025-01-31 | 15,912,962 | -4.1% | 1,399,531 | 11.37 |
| 2025-01-15 | 16,592,904 | +1.9% | 1,345,829 | 12.33 |
| 2024-12-31 | 16,292,256 | -1.6% | 1,272,819 | 12.80 |
| 2024-12-13 | 16,548,558 | +2.4% | 2,855,514 | 5.80 |
| 2024-11-29 | 16,156,619 | -1.2% | 1,027,825 | 15.72 |
| 2024-11-15 | 16,351,130 | -9.9% | 1,701,746 | 9.61 |
| 2024-10-31 | 18,144,306 | +8.9% | 1,417,862 | 12.80 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of RVMD volume is 54.6%, down 4.0 points over the last five sessions. Over the last 30 readings it ranged from 45.6% (6 October 2026) to 73.0% (24 September 2026). The latest reading is 3.0 points below the 30-session average of 57.6%, on 373K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 204K | 373K | 54.6% | 2 |
| 2026-10-27 | 289K | 496K | 58.2% | 10 |
| 2026-10-26 | 419K | 744K | 56.3% | 186 |
| 2026-10-23 | 282K | 580K | 48.6% | 186 |
| 2026-10-22 | 398K | 672K | 59.2% | 875 |
| 2026-10-21 | 546K | 932K | 58.6% | 3,532 |
| 2026-10-20 | 1.1M | 1.5M | 72.0% | 3,276 |
| 2026-10-19 | 475K | 937K | 50.7% | 223 |
| 2026-10-16 | 680K | 1.3M | 52.0% | 808 |
| 2026-10-15 | 409K | 786K | 52.0% | 252 |
| 2026-10-14 | 919K | 1.3M | 68.7% | 991 |
| 2026-10-13 | 786K | 1.6M | 48.1% | 301 |
| 2026-10-12 | 398K | 789K | 50.5% | 271 |
| 2026-10-09 | 507K | 918K | 55.2% | 11,485 |
| 2026-10-08 | 1.4M | 2.5M | 54.0% | 20,244 |
| 2026-10-07 | 289K | 563K | 51.4% | 166 |
| 2026-10-06 | 397K | 869K | 45.6% | 5,219 |
| 2026-10-05 | 445K | 638K | 69.7% | 70 |
| 2026-10-02 | 373K | 667K | 56.0% | 0 |
| 2026-10-01 | 431K | 790K | 54.5% | 860 |
| 2026-09-30 | 530K | 766K | 69.2% | 2,395 |
| 2026-09-29 | 387K | 623K | 62.2% | 2,963 |
| 2026-09-28 | 377K | 645K | 58.4% | 202 |
| 2026-09-25 | 760K | 1.2M | 61.6% | 8,335 |
| 2026-09-24 | 1.6M | 2.1M | 73.0% | 3,898 |
| 2026-09-23 | 504K | 844K | 59.6% | 57 |
| 2026-09-22 | 342K | 727K | 47.0% | 3,013 |
| 2026-09-21 | 508K | 751K | 67.7% | 3,923 |
| 2026-09-18 | 619K | 1.2M | 52.2% | 8,489 |
| 2026-09-17 | 514K | 844K | 61.0% | 14,785 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 24 September 2026, the fails-to-deliver balance in RVMD is 119 shares, down 27 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (21 April 2026) to 167,291 shares (29 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-24 | 119 | $190.74 | $23K |
| 2026-09-22 | 146 | $192.76 | $28K |
| 2026-09-21 | 208 | $190.95 | $40K |
| 2026-09-16 | 462 | $204.86 | $95K |
| 2026-09-01 | 404 | $205.57 | $83K |
| 2026-07-30 | 1 | $180.92 | $181 |
| 2026-07-24 | 100 | $188.75 | $19K |
| 2026-07-23 | 100 | $183.03 | $18K |
| 2026-07-22 | 100 | $183.29 | $18K |
| 2026-07-20 | 12 | $186.16 | $2K |
| 2026-07-17 | 108 | $179.18 | $19K |
| 2026-07-06 | 778 | $189.24 | $147K |
| 2026-07-02 | 8,851 | $187.51 | $1.7M |
| 2026-06-29 | 167,291 | $182.08 | $30.5M |
| 2026-06-24 | 4 | $169.51 | $678 |
| 2026-06-22 | 16,264 | $162.99 | $2.7M |
| 2026-06-18 | 36 | $157.77 | $6K |
| 2026-06-17 | 31 | $156.58 | $5K |
| 2026-06-15 | 616 | $153.87 | $95K |
| 2026-06-12 | 3 | $149.23 | $448 |
| 2026-06-10 | 33 | $149.55 | $5K |
| 2026-06-05 | 995 | $155.69 | $155K |
| 2026-06-04 | 89 | $155.99 | $14K |
| 2026-05-26 | 3 | $151.56 | $455 |
| 2026-05-20 | 33 | $147.30 | $5K |
| 2026-05-15 | 3 | $149.47 | $448 |
| 2026-05-13 | 194 | $145.72 | $28K |
| 2026-05-05 | 5,713 | $147.90 | $845K |
| 2026-04-23 | 496 | $141.50 | $70K |
| 2026-04-21 | 1 | $146.23 | $146 |
Insider trades
SEC Form 4, newest first. JSONInsiders at RVMD reported 80 open-market sells worth $78.4M in the last 90 days and no open-market buys. Latest filing: Mancini Anthony (See Remarks) on 2026-10-26.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | Mancini Anthony | See Remarks | Sell | 2K | $186.99 | $432K | 40K |
| 2026-10-26 | Mancini Anthony | See Remarks | Exercise or conversion | 2K | $33.62 | $78K | 42K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Sell | 301 | $204.72 | $62K | 53K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Sell | 1K | $203.91 | $244K | 53K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Sell | 1K | $202.81 | $203K | 54K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Sell | 2K | $201.72 | $325K | 55K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Sell | 2K | $200.82 | $442K | 57K |
| 2026-09-29 | Sandler Alan B. | Chief Development Officer | Exercise or conversion | 6K | $58.84 | $353K | 59K |
| 2026-09-25 | Cislini Jeff | SVP & General Counsel | Sell | 765 | $207.32 | $159K | 52K |
| 2026-09-25 | Mancini Anthony | See Remarks | Sell | 3K | $200.54 | $626K | 40K |
| 2026-09-25 | Mancini Anthony | See Remarks | Exercise or conversion | 3K | $33.62 | $105K | 43K |
| 2026-09-24 | Mancini Anthony | See Remarks | Sell | 587 | $200.00 | $117K | 40K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Sell | 100 | $195.15 | $20K | 4K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Sell | 2K | $194.59 | $292K | 4K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Sell | 3K | $193.44 | $512K | 6K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Sell | 5K | $192.54 | $960K | 9K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Sell | 910 | $191.85 | $175K | 14K |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Exercise or conversion | 5K | $1.12 | $6K | 14K |
| 2026-09-18 | Mancini Anthony | See Remarks | Sell | 2K | $196.94 | $347K | 40K |
| 2026-09-16 | Anders Jack | Chief Financial Officer | Sell | 4K | $199.30 | $796K | 119K |
| 2026-09-16 | Anders Jack | Chief Financial Officer | Sell | 61 | $195.00 | $12K | 123K |
| 2026-09-16 | Cislini Jeff | SVP & General Counsel | Sell | 3K | $199.30 | $660K | 53K |
| 2026-09-16 | Cislini Jeff | SVP & General Counsel | Sell | 52 | $195.01 | $10K | 56K |
| 2026-09-16 | GOLDSMITH MARK A | See Remarks | Sell | 14K | $199.30 | $2.7M | 253K |
| 2026-09-16 | GOLDSMITH MARK A | See Remarks | Sell | 213 | $195.01 | $42K | 267K |
| 2026-09-16 | Horn Margaret A | Chief Operating Officer | Sell | 5K | $199.30 | $975K | 150K |
| 2026-09-16 | Horn Margaret A | Chief Operating Officer | Sell | 76 | $195.01 | $15K | 155K |
| 2026-09-16 | Kelsey Stephen Michael | See Remarks | Sell | 5K | $199.30 | $1.1M | 286K |
| 2026-09-16 | Kelsey Stephen Michael | See Remarks | Sell | 85 | $195.01 | $17K | 292K |
| 2026-09-16 | Mancini Anthony | See Remarks | Sell | 2K | $199.30 | $348K | 42K |
| 2026-09-16 | Mancini Anthony | See Remarks | Sell | 27 | $195.05 | $5K | 44K |
| 2026-09-16 | Sandler Alan B. | Chief Development Officer | Sell | 336 | $199.30 | $67K | 53K |
| 2026-09-16 | Sandler Alan B. | Chief Development Officer | Sell | 5 | $194.96 | $975 | 53K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 3K | $205.81 | $673K | 292K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 5K | $204.84 | $1.0M | 295K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 18K | $203.87 | $3.7M | 300K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 19K | $203.06 | $3.8M | 318K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 21K | $201.75 | $4.3M | 337K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 13K | $200.78 | $2.7M | 358K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 12K | $200.11 | $2.4M | 372K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Sell | 800 | $198.55 | $159K | 384K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Exercise or conversion | 40K | $40.74 | $1.6M | 384K |
| 2026-09-11 | Kelsey Stephen Michael | See Remarks | Exercise or conversion | 53K | $42.45 | $2.2M | 344K |
| 2026-09-10 | Mancini Anthony | See Remarks | Sell | 300 | $207.17 | $62K | 44K |
| 2026-09-10 | Mancini Anthony | See Remarks | Sell | 1K | $206.10 | $243K | 44K |
| 2026-09-10 | Mancini Anthony | See Remarks | Sell | 2K | $205.05 | $496K | 45K |
| 2026-09-10 | Mancini Anthony | See Remarks | Sell | 6K | $204.14 | $1.1M | 48K |
| 2026-09-10 | Mancini Anthony | See Remarks | Sell | 6K | $203.28 | $1.2M | 53K |
| 2026-09-10 | Mancini Anthony | See Remarks | Exercise or conversion | 9K | $33.62 | $315K | 59K |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 371 | $212.27 | $79K | 0 |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 4K | $211.36 | $812K | 371 |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 5K | $210.50 | $996K | 4K |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 3K | $209.56 | $598K | 9K |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 4K | $208.55 | $748K | 12K |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 999 | $207.33 | $207K | 15K |
| 2026-09-08 | Kim Lorence H. | Director | Sell | 706 | $206.60 | $146K | 16K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 625 | $206.15 | $129K | 17K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 2K | $205.19 | $437K | 18K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 7K | $204.35 | $1.5M | 20K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 26K | $203.55 | $5.3M | 27K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 13K | $202.48 | $2.6M | 53K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 7K | $201.47 | $1.3M | 66K |
| 2026-08-31 | Kim Lorence H. | Director | Sell | 300 | $200.56 | $60K | 73K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 126 | $212.06 | $27K | 61K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 229 | $211.46 | $48K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 126 | $210.40 | $27K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 1K | $209.27 | $294K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 937 | $208.36 | $195K | 63K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 177 | $207.25 | $37K | 64K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 127 | $212.06 | $27K | 61K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 245 | $211.47 | $52K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 136 | $210.40 | $29K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 1K | $209.28 | $283K | 62K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 951 | $208.36 | $198K | 63K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 190 | $207.25 | $39K | 64K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 4K | $212.08 | $768K | 267K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 7K | $211.33 | $1.4M | 271K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 4K | $210.25 | $802K | 278K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 36K | $209.26 | $7.5M | 281K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 25K | $208.37 | $5.2M | 317K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Sell | 5K | $207.23 | $1.1M | 342K |
| 2026-08-21 | GOLDSMITH MARK A | See Remarks | Exercise or conversion | 80K | $4.73 | $378K | 347K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 3K | $212.06 | $703K | 56K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 5K | $211.34 | $951K | 59K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 3K | $210.26 | $534K | 64K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 26K | $209.25 | $5.4M | 66K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 17K | $208.37 | $3.6M | 92K |
| 2026-08-21 | Cislini Jeff | General Counsel | Sell | 3K | $207.24 | $705K | 109K |
| 2026-08-21 | Cislini Jeff | General Counsel | Exercise or conversion | 27K | $21.61 | $575K | 113K |
| 2026-08-21 | Cislini Jeff | General Counsel | Exercise or conversion | 30K | $18.56 | $551K | 86K |
| 2026-06-29 | Patel Sushil | Director | Sell | 300 | $187.83 | $56K | 24K |
| 2026-06-29 | Patel Sushil | Director | Sell | 881 | $192.61 | $170K | 22K |
| 2026-06-29 | Patel Sushil | Director | Sell | 541 | $191.87 | $104K | 23K |
| 2026-06-29 | Patel Sushil | Director | Sell | 600 | $190.54 | $114K | 23K |
| 2026-06-29 | Patel Sushil | Director | Sell | 100 | $188.57 | $19K | 24K |
| 2026-06-29 | Patel Sushil | Director | Sell | 858 | $186.92 | $160K | 24K |
| 2026-06-29 | Patel Sushil | Director | Sell | 1K | $185.90 | $204K | 25K |
| 2026-06-29 | Patel Sushil | Director | Sell | 900 | $184.59 | $166K | 26K |
| 2026-06-29 | Patel Sushil | Director | Sell | 300 | $183.17 | $55K | 27K |
| 2026-06-29 | Patel Sushil | Director | Exercise or conversion | 3K | $37.54 | $111K | 27K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for RVMD worth $128.0M at the prices reported; 18 in the last 90 days worth $69.7M. Latest: ALAN SANDLER filed on 2026-09-29 to sell 6,309 shares ($1.3M) from 2026-09-29.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-29 | ALAN SANDLEROfficer | 6K | $1.3M | 0.003% | 2026-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-25 | ANTHONY MANCINIOfficer | 9K | $1.9M | 0.004% | 2026-09-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-24 | ANTHONY MANCINIOfficer | 587 | $112K | 0.000% | 2026-09-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-22 | Elizabeth AndersonDirector | 15K | $2.9M | 0.007% | 2026-09-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-18 | ANTHONY MANCINIOfficer | 2K | $347K | 0.001% | 2026-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-15 | Anders JackOfficer | 4K | $803K | 0.002% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Cislini JeffOfficer | 3K | $667K | 0.002% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Goldsmith Mark AOfficer, Director | 14K | $2.8M | 0.006% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Horn Margaret AOfficer | 5K | $984K | 0.002% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Kelsey Stephen MichaelOfficer | 5K | $1.1M | 0.003% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Mancini AnthonyOfficer | 2K | $484K | 0.001% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-15 | Sandler Alan BOfficer | 331 | $67K | 0.000% | 2026-09-15 | ETRADE Financial Corporation |
| 2026-09-11 | STEPHEN KELSEYOfficer | 93K | $18.8M | 0.043% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-10 | ANTHONY MANCINIOfficer | 15K | $3.2M | 0.007% | 2026-09-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | THE JONATHAN GOLDSMITH REVOCABLE TRUSTDirector, Officer | 3K | $635K | 0.001% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | THE REBECCA GOLDSMITH REVOCABLE TRUSTDirector, Officer | 3K | $635K | 0.001% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | MARK A GOLDSMITHDirector, Officer | 80K | $16.9M | 0.037% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | JEFFREY TODD CISLINIOfficer | 76K | $16.1M | 0.035% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-29 | SUSHIL PATELDirector | 6K | $1.0M | 0.003% | 2026-06-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-24 | JACK ANDERSOfficer | 20K | $3.4M | 0.009% | 2026-06-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | Mancini AnthonyOfficer | 4K | $648K | 0.002% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-15 | Kelsey Stephen MichaelOfficer | 4K | $626K | 0.002% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-15 | MARGARET A HORNOfficer | 90K | $13.8M | 0.042% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | Horn Margaret AOfficer | 3K | $536K | 0.002% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-15 | GOLDSMITH MARK AOfficer, Director | 10K | $1.5M | 0.005% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-15 | Cislini JeffOfficer | 2K | $255K | 0.001% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-15 | Anders JackOfficer | 3K | $408K | 0.001% | 2026-06-15 | ETRADE Financial Corporation |
| 2026-06-11 | MARGARET A HORNOfficer | 10K | $1.4M | 0.005% | 2026-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-26 | ANTHONY MANCINIOfficer | 3K | $473K | 0.001% | 2026-05-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-27 | ANTHONY MANCINIOfficer | 3K | $422K | 0.002% | 2026-04-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | MARK A GOLDSMITHDirector, Officer | 120K | $17.6M | 0.061% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-19 | JEFFREY TODD CISLINIOfficer | 1K | $114K | 0.001% | 2026-03-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-13 | Wei LinOfficer | 2K | $228K | 0.001% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | Wang XiaolinOfficer | 2K | $227K | 0.001% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | Kelsey Stephen MichaelOfficer | 4K | $389K | 0.002% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | Horn Margaret AOfficer | 5K | $470K | 0.002% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | GOLDSMITH MARK AOfficer, Director | 13K | $1.3M | 0.007% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | Cislini JeffOfficer | 2K | $204K | 0.001% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-13 | Anders JackOfficer | 2K | $213K | 0.001% | 2026-03-16 | ETRADE Financial Corporation |
| 2026-03-02 | JONATHAN GOLDSMITH REVOCABLE TRUSTDirector, Officer | 3K | $306K | 0.002% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | THE REBECCA GOLDSMITH REVOCABLE TRUSTDirector, Officer | 3K | $306K | 0.002% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | MARK A GOLDSMITHDirector, Officer | 30K | $3.1M | 0.015% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-21 | JEFFREY TODD CISLINIOfficer | 908 | $106K | 0.000% | 2026-01-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-07 | MARGARET A HORNOfficer | 75K | $6.0M | 0.039% | 2026-01-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-07 | JACK LEE ANDERSOfficer | 10K | $799K | 0.005% | 2026-01-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-12 | Kelsey Stephen MichaelOfficer | 5K | $412K | 0.003% | 2025-12-15 | ETRADE Financial Corporation |
| 2025-12-12 | Horn Margaret AOfficer | 5K | $367K | 0.002% | 2025-12-15 | ETRADE Financial Corporation |
| 2025-12-12 | GOLDSMITH MARK AOfficer, Director | 15K | $1.2M | 0.008% | 2025-12-15 | ETRADE Financial Corporation |
| 2025-12-12 | Cislini JeffOfficer | 3K | $203K | 0.001% | 2025-12-15 | ETRADE Financial Corporation |
| 2025-12-12 | Anders JackOfficer | 3K | $235K | 0.002% | 2025-12-15 | ETRADE Financial Corporation |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON24 holders report 5% or more of RVMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Roberts, Jr., Thomas G. at 6.4% of the class (13,564,149 shares), filed 2026-08-13 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | Baker Bros. Advisors (GP) LLCparent holding company, other entity | 11.4M | 5.3% | 2026-06-30 |
| 2026-08-14 | 13G | Julian C. Bakerparent holding company, individual | 11.4M | 5.3% | 2026-06-30 |
| 2026-08-14 | 13G | Felix J. Bakerparent holding company, individual | 11.4M | 5.3% | 2026-06-30 |
| 2026-08-14 | 13G | Baker Bros. Advisors LPinvestment adviser, partnership | 11.4M | 5.3% | 2026-06-30 |
| 2026-08-13 | 13G | JANUS HENDERSON GROUP Ltd.parent holding company | 10.7M | 5.1% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Roberts, Jr., Thomas G.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Saito Edric C.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Short Daniel S.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Spokes, Andrew J. M.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Warren, John R.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Wehrly, Mark C.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Management, L.L.C.investment adviser, other entity | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Giauque, Nicolasparent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Kim, David T.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Linn, Michael G.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Luo Patrick (Cheng)parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Husen, Avner A.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Dapice Joshua J.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Dreyfuss, Philip D.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Dunn Hannah E.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Gehani, Varun N.parent holding company, individual | 13.6M | 6.4% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital F5 Master I, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Institutional Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Institutional Partners II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Institutional Partners III, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Four Crossings Institutional Partners V, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital Offshore Investors II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Capital (AM) Investors, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Healthcare Partners Master, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Partners, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Institutional (GP) V, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon F5 (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 4 | Farallon Healthcare Partners (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-07-29 | 13G | BlackRock, Inc.parent holding company | 12.2M | 5.7% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 4 | JANUS HENDERSON GROUP PLCparent holding company | 9.8M | 4.9% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 4 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-10 | 13G/Ano. 7 | Wellington Investment Advisors Holdings LLPparent holding company | 7.0M | 3.6% | 2025-12-31 |
| 2026-02-10 | 13G/Ano. 7 | Wellington Group Holdings LLPparent holding company | 7.0M | 3.6% | 2025-12-31 |
| 2026-02-10 | 13G/Ano. 7 | Wellington Management Group LLPparent holding company | 7.0M | 3.6% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 3 | Fried, Richard Bindividual | 0 | 0.0% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 3 | Patel, Rajiv A.individual | 0 | 0.0% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 3 | Seybold, Williamindividual | 0 | 0.0% | 2025-12-31 |
| 2025-11-05 | 13G | Abigail P. Johnsonindividual | 9.4M | 5.0% | 2025-09-30 |
| 2025-11-05 | 13G | FMR LLCparent holding company | 9.4M | 5.0% | 2025-09-30 |
13F holders
Tracked managers holding RVMD at their latest 13F. JSON8 of the 30 tracked managers held RVMD at their latest 13F, $659.1M in total at quarter-end prices. AQR Capital Management is the largest at $242.6M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 1.3M | $242.6M | 0.08% | +1.2M |
| Two Sigma Investments | 2026-06-30 | 738K | $138.2M | 0.10% | -821K |
| Citadel Advisors | 2026-06-30 | 590K | $110.5M | 0.01% | +190K |
| Duquesne Family Office | 2026-06-30 | 400K | $74.8M | 1.44% | +84K |
| Millennium Management | 2026-06-30 | 216K | $40.5M | 0.01% | -161K |
| Fisher Asset Management | 2026-06-30 | 208K | $38.9M | 0.01% | -8K |
| Point72 Asset Management | 2026-06-30 | 60K | $11.3M | 0.01% | new |
| D. E. Shaw & Co. | 2026-06-30 | 12K | $2.3M | 0.00% | -1.0M |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated -$897.7M of operating cash flow.
- Cash
- $815.4M
- Equity
- $2.61B
- Total assets
- $4.32B
- Shares outstanding
- 214,336,418
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | n/a | -$644.4M | n/a | -3.06 |
| Q1 FY 2026 | 2026-03-31 | n/a | -$453.8M | n/a | -2.29 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$364.9M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$305.2M | n/a | -1.61 |
| Q2 FY 2025 | 2025-06-30 | n/a | -$247.8M | n/a | -1.31 |
| Q1 FY 2025 | 2025-03-31 | n/a | -$213.4M | n/a | -1.13 |
| Q4 FY 2024derived | 2024-12-31 | $0 | -$194.6M | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $0 | -$156.3M | n/a | -0.94 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | -$1.13B | -$897.7M | $16.0M | n/a | n/a |
| FY 2024 | 2024-12-31 | $0 | -$600.1M | -$557.4M | $10.3M | n/a | n/a |
| FY 2023 | 2023-12-31 | $11.6M | -$436.4M | -$350.6M | $7.7M | n/a | n/a |
| FY 2022 | 2022-12-31 | $35.4M | -$248.7M | -$224.4M | $10.8M | n/a | n/a |
| FY 2021 | 2021-12-31 | $29.4M | -$187.1M | -$147.2M | $6.5M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Revolution Medicines in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Revolution Medicines (RVMD), SEC CIK 1628171, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-29.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-26.JSON and CSV
- Company record
- EDGAR filing index for CIK 1628171Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
Datasets
Frequently Asked Questions
How much of RVMD is sold short?
What is RVMD's daily short volume?
Does RVMD have fails to deliver?
Are RVMD insiders buying or selling?
Have RVMD insiders filed to sell?
Who owns 5% or more of RVMD?
What did RVMD report last quarter?
Which tracked 13F managers own RVMD?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.